Breast Ultrasound for Women Under 40
Why ultrasound rather than mammography is usually the right first test before 40, what dense breast tissue actually means, and where the NHS pathway fits.
If you are under 40 and have found a breast lump or noticed a change, the imaging you are offered will usually differ from what an older woman would receive — and that is deliberate rather than a lesser standard of care. Ultrasound is generally the first-line test in younger women, for a reason rooted in physics rather than policy: younger breast tissue tends to be denser, and dense tissue is exactly what mammography struggles to see through.
Being under 40 does not change this. See your GP promptly about a new lump, a change in breast size or shape, skin dimpling or puckering, nipple inversion or discharge, or swelling in the armpit — they can refer you into the NHS breast clinic pathway. A private scan can run alongside that referral; it is not a substitute for it.
Dense breast tissue, and the white-on-white problem
Breast density describes how much fibrous and glandular tissue there is relative to fat. It has nothing to do with breast size or firmness — it is a radiological property, visible only on imaging, and it decreases for most women with age.
Here is why it matters. On a mammogram, dense tissue appears white. Cancers also appear white. Looking for a white lesion against a white background is genuinely difficult, and sensitivity falls as density rises. Ultrasound does not have this problem: it distinguishes tissue by how it reflects sound rather than by X-ray absorption, so a fluid-filled cyst appears black, a solid mass appears grey, and both stand out against surrounding tissue regardless of density. That is the entire case for scanning younger women first, and our guide to breast density covers it in more depth.
Ultrasound also avoids ionising radiation, which matters more in younger women whose breast tissue is more radiosensitive, and it can be repeated as often as clinically useful without a cumulative dose.
Ultrasound and mammography compared
| Ultrasound | Mammography | |
|---|---|---|
| Performs best | Dense tissue; younger women | Fattier tissue; typically from around 40 upward |
| Radiation | None | Low-dose X-ray |
| Strongest at | Telling fluid from solid; characterising a lump you can feel | Detecting microcalcifications, which can be an early cancer sign |
| Main limitation | Does not reliably show microcalcifications | Sensitivity drops in dense tissue |
| Comfort | Gel and probe pressure | Breast compression, briefly uncomfortable |
They are complementary rather than competing, which is why women over 40 are often offered both. Under 40 the balance favours ultrasound — but if a finding suggests microcalcifications or the clinical picture warrants it, mammography may still be added, arranged through your GP or the breast clinic.
What the NHS offers, and what it does not
Two different things get confused here. NHS breast screening is for women without symptoms and begins at around 50 — younger women are not routinely screened, because the balance of benefit and harm differs at lower background risk. Investigation of a symptom has no age limit at all: a lump at 28 warrants assessment exactly as it would at 58, through your GP and the breast clinic pathway.
There is a third group. Women with a significant family history or a known genetic predisposition may be eligible for earlier surveillance through the NHS familial breast cancer pathway, which can begin well before 50 and may include MRI. That is arranged via your GP, who can refer for family-history assessment — and it is worth raising specifically if close relatives were diagnosed young. A private scan does not substitute for that pathway; if you might qualify, the referral is the more valuable thing to pursue.
What the scan involves and what it finds
You undress to the waist and lie back with the arm raised on the side being examined. Warm gel, a small probe, and roughly 20 to 30 minutes covering both breasts and the armpits, where lymph nodes are assessed. It is painless, uses no radiation, and the images appear live — so findings are shown and explained as they are found.
The commonest findings in this age group are reassuring ones: simple cysts, and fibroadenomas — smooth, mobile, benign solid lumps that are the most frequent solid finding in younger women and typically need monitoring rather than removal. Where features are not straightforwardly benign, the report says so plainly and recommends tissue diagnosis, so your GP can refer without needing a second opinion first.
Your questions answered
Why do I get an ultrasound instead of a mammogram under 40?
What does dense breast tissue mean?
Can breast ultrasound detect cancer in young women?
Should I have breast screening if I am under 40?
What is a fibroadenoma?
Does a family history change what I should do?
How often should I check my breasts?
Where to go from here
How a scan tells a simple cyst from something needing more.
Read the guide →
DensityDense Breasts ExplainedWhat density means for what each type of imaging can see.
Read the guide →
£189Breast Ultrasound ScanThe examination itself — what it covers and how to book.
About the scan →
The right first test for younger breasts
Breast ultrasound by HCPC-registered sonographers, both breasts and armpits assessed, findings shown on screen, and a written report usually within two hours for your GP.
Kensington, London W8 4ED
3 mins from Notting Hill Gate
This article is general information, not individual medical advice. Any new breast lump or change should be assessed by your GP, who can refer you into the NHS breast clinic pathway or for family-history assessment where appropriate. Imaging describes findings; only a biopsy provides a diagnosis.
Written and clinically reviewed by the HCPC-registered sonographers who perform this scan at IUS London — a CQC-registered diagnostic ultrasound clinic (Provider ID 1-2775844974). Your own findings are explained to you at the scan and set out in your report.
Author: Yianni Kiromitis, Senior Sonographer, HCPC RA38415
Medically reviewed: 1 August 2026
